Inflammation Found to Drive Early Artery Disease

A CNIC-led study links inflammation to early atherosclerosis independently of cholesterol and blood pressure.

Updated on Nov. 12, 2026 in Heart Disease

Vector-style editorial illustration of coral-red blood vessels, several narrowed by rust-brown plaque while one stays clear, on a cream background.
Researchers at Spain's CNIC found inflammation drives early artery plaque buildup independently of cholesterol and blood pressure, in a 3,471-person study. AI Illustration. Upload story photo >

Live Poll

Do you get regular checkups that include blood tests for heart risk?

Researchers from the Spanish National Centre for Cardiovascular Research (CNIC) found that inflammation contributes to the early development of atherosclerosis independently of LDL cholesterol and blood pressure. The findings, published in the European Heart Journal, are based on the PESA study of 3,471 middle-aged adults without known cardiovascular disease.

Why it matters

Current risk assessment relies heavily on cholesterol and blood pressure, so identifying a separate inflammatory pathway could help flag people at higher risk before symptoms appear. The results suggest inflammation may be a useful target for earlier intervention.

The study followed 3,471 middle-aged men and women for six years using vascular ultrasound and coronary CT, finding white blood cell count to be the inflammatory marker that best reflects early atherosclerotic disease. Whether lowering inflammation changes long-term cardiovascular outcomes has not yet been tested in this cohort.

The players

Spanish National Centre for Cardiovascular Research (CNIC)

CNIC is a leading Spanish research institute focused on the study of cardiovascular disease, and it funded and led the PESA study.

European Heart Journal

The European Heart Journal is a peer-reviewed cardiology publication of the European Society of Cardiology in which the study was published.

The details

Researchers tracked participants with advanced vascular imaging and analyzed several inflammatory biomarkers. Inflammation was associated with greater plaque buildup and more extensive involvement of the carotid, femoral and coronary arteries. The PESA study is funded by CNIC and Banco Santander.

Timeline

  1. PESA participants were followed over a six-year period.

Health Landscape

The PESA study adds to a growing body of research that treats inflammation as a driver of atherosclerosis alongside traditional lipid and blood pressure risk factors. If the inflammatory pathway is confirmed, it could expand how cardiovascular risk is assessed beyond cholesterol-based screening.

Inflammatory blood markers such as white blood cell count may one day be used alongside cholesterol and blood pressure to identify higher-risk adults earlier. For now, the findings are research results and do not change current screening or treatment recommendations.

The takeaway

Inflammation appears to contribute to artery damage even when cholesterol and blood pressure look normal. Discussing inflammatory risk markers with a clinician may become more relevant as this research develops.

Further reading

For more on the conditions behind these findings, explore our Heart Disease section.

Source note: This article includes information reported by Biotech-spain.

Live Poll

Do you get regular checkups that include blood tests for heart risk?